---
title: Hypertension
author: J. Austin Straley, DO
date: 2024-03-16
categories:
    - Cardiology
---

## Asymptomatic Hypertension
* [Article][1]
* [Asymptomatic Inpatient Hypertension][3]
* [Things We Do For No Reason: Antihypertensives Inpatient][4]



## [Management][2]
- [DASH: Small but significant BP reductions from diet control](http://www.ncbi.nlm.nih.gov/pubmed/9099655){:target="_blank"}
- [LIFE: Losartan > Atenolol for same BP Reduction](https://pubmed.ncbi.nlm.nih.gov/11937179/){:target="_blank"}
- [ALLHAT: Thiazide = CCB = ACEI in High-risk HTN, Thiazides may be better](https://pubmed.ncbi.nlm.nih.gov/12479763/){:target="_blank"}
- [ACCOMPLISH: CCBs > Diuretics when added to ACEI in High-risk HTN](https://pubmed.ncbi.nlm.nih.gov/19052124/){:target="_blank"}
- [Thiazides less effective in obese, CCBs equal across weight](https://pubmed.ncbi.nlm.nih.gov/23219284/){:target="_blank"}
- [HOPE: ACEI significantly reduces rate of HF in High-risk patients](https://pubmed.ncbi.nlm.nih.gov/12628949/){:target="_blank"}
- Inpatient
    - [Hydralazine vs. Labetalol Inpatient](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673377/){:target="_blank"}
- [Resistant Hypertension](https://pubmed.ncbi.nlm.nih.gov/27895136/){:target="_blank"}

[1]: https://www.annemergmed.com/article/S0196-0644(13)00445-9/fulltext{:target="_blank"}
[2]: https://pubmed.ncbi.nlm.nih.gov/29146535/{:target="_blank"}
[3]: https://pubmed.ncbi.nlm.nih.gov/30811320/{:target="_blank"}
[4]: https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.13185{:target="_blank"}